Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : The Justa & Lars Honors Bob Brinker Investment Club -- Ignore unavailable to you. Want to Upgrade?

To: Justa Werkenstiff who wrote (10465)	12/15/1999 4:26:00 PM
From: Wally Mastroly	Read Replies (2) \| Respond to of 15132

Justa, Re: I think the Administration's jawboning has no meat behind it. I believe our entire oil reserve is only enough for a couple of months of US consumption. Don't think release of the entire amount would have more than a very short term impact on oil prices (if that). (Not to mention, I thought those reserves were only for a real emergency - not a political one of rising prices).

To: Justa Werkenstiff who wrote (10465)	12/15/1999 5:25:00 PM
From: marc ultra	Read Replies (2) \| Respond to of 15132

Justa re<<<<Got Freemarket? Ouch, baby, glad I did not chase this in the aftermarket. >>>> At a small fraction of 1% of my portfolio I have a lot more serious things to go ouch about. One of my biotechs ISIP which I've accumulated over the last 3 years blew up in the most bizarre way. I will bore people with some of the details since it makes another emphasis on the 4% rule. The company got an interim look several months back at an interim data analysis on a study of their lead drug. It looked so good the company allocated major resources and plans for the drug's manufacture and approval. This interim look included 150 patients. The company got a final look at the results Monday for all 300 patients and for some bizarre reason which no explanation can be found the second 150 patients did so mediocre it sounded almost like the mirror image of the first 150 patients and the trial was declared a failure. They looked at all the logical suspects but couldn't find an explanation why this happened. The conference call sounded more like a wake than a cc. The stock was sliced by around 70%. The only fortunate thing was my holdings were limited to about 5% of my portfolio. I sold some of my holdings I purchased at relatively high prices for tax loss purposes as this should be a broken stock and a very damaged company for some time now. Marc

To: Justa Werkenstiff who wrote (10465)	12/16/1999 12:53:00 PM
From: Trebor	Respond to of 15132

>Got Freemarket? Ouch, baby, glad I did not chase this in the aftermarket.< A little chasing yesterday might have been in order. Stock is currently up 13 points, or 6%. I almost bought in when the stock was in the low 220's but fear won out over greed. Time will tell. I am anxious for them to begin options trading on this stock. I've often found that selling in-the-money puts is a way to get into a stock at a price I feel comfortable with. And if you don't get the stock "put" to you, you collect an option premium for taking the risk.